超酸合成的化二胺作为选择性hCA IV抑制剂起作用
Emanuela Berrino1,2, Bastien Michelet1, Kassandra Vitse1
1Superacid Group in "Organic Synthesis" Team, Université de Poitiers, CNRS UMR 7285 IC2MP, Bât. B28, 4 rue Michel Brunet, TSA 51106, 86073 Poitiers Cedex 09, France.
研究人员开发了新的β-(di) 基二胺作为碳酸酶 (CA) IV的选择性抑制剂. 这一发现为准CA IV提供了一种新的方法,CA IV是一种在各种生理和病理过程中至关重要的酶.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 碳酸无水酶 (CA) IV是一种与膜结合的酶,涉及至关重要的生理和病理过程.
- 尽管CA IV很重要,但由于缺乏选择性抑制剂,CA IV在很大程度上仍未被探索.
- 选择性CA IV抑制剂在治疗和研究应用中非常受欢迎.
研究的目的:
- 发现和描述新型选择性抑制碳酸无水酶IV的新型选择性抑制剂.
- 确定负责强大和选择性CA IV抑制的关键结构特征.
- 通过分子建模阐明新合成的抑制剂的结合模式.
主要方法:
- 新型β-(di) 基胺化合物的合成.
- 在体外酶抑制试验测试以确定对CA IV的效力和选择性.
- 分子建模和结构分析以了解抑制剂-酶相互作用.
主要成果:
- β-(di) 基二胺证明有效抑制了碳酸无水酶IV.
- 鉴定出N-propyldiamine核心对于强有力的和选择性的CA IV抑制至关重要.
- 分子建模提供了关于CA IV活性位点内的结合相互作用的见解.
结论:
- β-(di) 烯酸胺是一种有前途的新型选择性CA IV抑制剂.
- N-基胺支架为针对CA IV提供了一个新的策略.
- 对这些抑制剂的进一步研究可能会导致针对CA IV相关疾病的新疗法.
更多相关视频
06:34Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
Published on: June 20, 2014
09:04A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
相关概念视频
Diazonium Group Substitution: –OH and –H
Preparation of Acid Anhydrides
The carboxylate ion acts as a nucleophile that attacks the carbonyl carbon of the acid chloride to form a tetrahedral intermediate. Subsequently, the re-formation of the carbonyl group with the loss of the chloride ion as a leaving group leads to the formation of an acid...
Amines to Sulfonamides: The Hinsberg Test
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing...
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
Preparation of 1° Amines: Gabriel Synthesis
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
ortho–para-Directing Deactivators: Halogens
